VANDA PHARMACEUTICALS INC. (VNDA) Net margin 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) net profit margin by fiscal year — reported net income divided by reported revenue.
-102.0%FY2025 · since FY2016: -12.3% → -102.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -102.0% | -92.5 pp |
| FY2024 | -9.5% | -10.8 pp |
| FY2023 | 1.3% | -1.2 pp |
| FY2022 | 2.5% | -9.9 pp |
| FY2021 | 12.4% | +3.0 pp |
| FY2020 | 9.4% | -41.5 pp |
| FY2019 | 50.9% | +37.8 pp |
| FY2018 | 13.1% | +22.5 pp |
| FY2017 | -9.4% | +2.9 pp |
| FY2016 | -12.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice